Pituitary Function Tests: Recommendations and Indications

General Indications for Pituitary Function Testing

• The American Association of Neurological Surgeons recommends routine endocrine evaluation of all anterior pituitary axes for patients with suspected pituitary disorders, particularly those with nonfunctioning pituitary adenomas (NFPAs), due to the high prevalence of hypopituitarism in these patients, affecting 37-85% of patients with NFPAs 1, 2
• Complete evaluation of all anterior pituitary hormone axes is necessary as panhypopituitarism occurs in 6-29% of patients with pituitary disorders, according to the American Association of Neurological Surgeons 1, 3

Specific Testing Recommendations

• Routine evaluation of all anterior pituitary axes is recommended to assess for hypopituitarism (level II recommendation) in patients with NFPAs, as suggested by the American Association of Neurological Surgeons 1, 2
• Routine prolactin testing is recommended in all patients with suspected NFPA to rule out hypersecretion that might not be clinically suspected (level II recommendation), according to the American Association of Neurological Surgeons 1, 2

Testing in Special Populations

• Genetic assessment should be offered to all children and young people with pituitary adenomas to inform management and family surveillance (strong recommendation, high-quality evidence), as recommended by the Endocrine Society 4
• Genetic testing should be offered to all children and young people with growth hormone and prolactin excess due to high prevalence of genetic abnormalities in these tumors (strong recommendation, high-quality evidence), according to the Endocrine Society 4

Timing of Tests

• For assessment of GH deficiency after pituitary surgery, wait at least 6-12 months after surgery before testing, as HPA axis recovery is often delayed, as suggested by the Endocrine Society 5
• In children with Cushing's disease, evaluate for GH deficiency 3-6 months after surgery, according to the Endocrine Society 5

Clinical Pearls and Pitfalls

• The most commonly affected pituitary axis in NFPAs is the GH axis (61-100% of patients), followed by gonadal axis (36-96%), adrenal axis (17-62%), and thyroid axis (8-81%), as reported by the American Association of Neurological Surgeons 1, 2
• Patients with 3 or more pituitary hormone deficiencies are more likely to have GH deficiency and do not need dynamic testing, according to the Endocrine Society 5
• Diabetes insipidus is uncommon in NFPAs, reported in only 7% of patients at presentation, as noted by the American Association of Neurological Surgeons 1
• Replacement for adrenal insufficiency and significant hypothyroidism is recommended in all patients preoperatively (level II recommendation), as suggested by the American Association of Neurological Surgeons 1, 2

Diagnosing Hypopituitarism with Blood Tests

Initial Laboratory Evaluation

• Morning baseline hormone measurements should include thyroid function, adrenal function, glycemic control, and gonadal function, as recommended by the Endocrine Society, with measurements such as TSH, free T4, ACTH, cortisol, glucose, HbA1c, testosterone, estradiol, FSH, and LH 6, 7, 8
• Insulin-like growth factor 1 (IGF-1) evaluation is recommended to assess growth hormone status and rule out GH hypersecretion, as suggested by the American Association of Clinical Endocrinologists 9

Dynamic Stimulation Tests

• For adrenal function, a 1 mcg cosyntropin stimulation test is recommended when baseline morning cortisol levels are equivocal, as recommended by the Endocrine Society 6, 10
• These tests should be performed prior to administration of steroids to avoid interference with results, as suggested by the American College of Endocrinology 8, 10

Diagnostic Criteria for Hypophysitis

• Proposed confirmation criteria include ≥1 pituitary hormone deficiency (TSH or ACTH deficiency required) combined with an MRI abnormality, or ≥2 pituitary hormone deficiencies (TSH or ACTH deficiency required) in the presence of headache and other symptoms, as recommended by the Pituitary Society 6, 8

Monitoring Schedule

• Thyroid function (TSH and free T4) should be repeated before each treatment cycle, as recommended by the American Thyroid Association 6, 7
• Early morning ACTH and cortisol levels should be monitored every month for 6 months, then every 3 months for 6 months, and then every 6 months for 1 year, as suggested by the Endocrine Society 6, 7

Interpretation of Results

• Central hypothyroidism presents with low free T4 with low/normal TSH, unlike primary hypothyroidism where TSH is elevated, as described by the American Association of Clinical Endocrinologists 6, 8
• Central adrenal insufficiency shows low cortisol with low/normal ACTH, as recommended by the Endocrine Society 6, 7
• Hypogonadotropic hypogonadism presents with low testosterone/estradiol with low/normal FSH and LH, as suggested by the American College of Endocrinology 6, 10

Special Considerations

• In cases of both adrenal insufficiency and hypothyroidism, steroids should always be started prior to thyroid hormone replacement to avoid precipitating an adrenal crisis, as recommended by the American Thyroid Association 8, 10
• MRI of the sella with pituitary cuts should be performed in patients with suspected hypophysitis or other structural causes of hypopituitarism, as suggested by the Pituitary Society 6, 8

Empty Sella Syndrome and Hypothyroidism

Diagnostic Approach

• The American College of Radiology recommends using high-resolution pituitary protocols in MRI as the preferred diagnostic modality to confirm empty sella, even without IV contrast 11

Clinical Implications

• The Endocrine Society suggests that all patients with partially empty sella require comprehensive hormonal screening, including thyroid function tests, to differentiate central from primary hypothyroidism 11
• The American Association of Clinical Endocrinologists recommends checking TSH levels to determine the type of hypothyroidism, with elevated TSH indicating primary hypothyroidism and low/normal TSH with low free T4 indicating central hypothyroidism 11

Hormonal Evaluation in Empty Sella Syndrome

Rationale for Comprehensive Screening

• Approximately 30% of patients with empty sella demonstrate some degree of hypopituitarism upon testing, though most remain asymptomatic 12

Specific Hormonal Panel to Order

Clinical Context Matters

Critical Management Pitfall

When to Refer to Endocrinology

Imaging Confirmation

Laboratory Evaluation and Management of Suspected Pituitary Dysfunction

1. Prevalence of Hormone Deficiencies in Pituitary Disorders

• Hypopituitarism is present in 37–85 % of individuals with pituitary pathology. (Endocrine clinical data) 13
• Growth‑hormone axis involvement is the most common, affecting 61–100 % of patients with non‑functioning adenomas. (Endocrine Society) 13
• Gonadal axis deficiency occurs in 36–96 % of such patients. (Endocrine Society) 13
• Adrenal axis deficiency is seen in 17–62 % of patients. (Endocrine Society) 13
• Thyroid axis deficiency is reported in 8–81 % of cases. (Endocrine Society) 13
• Panhypopituitarism occurs in 6–29 % of patients. (Endocrine Society) 13
• Diabetes insipidus is present at presentation in only about 7 % of patients. (Endocrine Society) 13

2. Baseline Laboratory Panel (Morning Fasting Samples)

• Thyroid axis: Measure serum TSH and free T4 to screen for central hypothyroidism. Low free T4 with low or inappropriately normal TSH suggests central disease. (American Thyroid Association) 14
• Adrenal axis: Obtain morning cortisol and ACTH levels to assess secondary adrenal insufficiency. Low cortisol with low/normal ACTH is indicative. (Endocrine Society) 14
• Growth‑hormone axis: Use IGF‑1 as the initial screening test for both GH deficiency and excess. (American Association of Clinical Endocrinology) 13
• Prolactin: Routine serum prolactin measurement detects hyperprolactinemia that may be clinically silent; prevalence in non‑functioning adenomas is 25–65 % (mean ≈ 39 ng/mL). (Endocrine Society) 13
• Electrolytes: Evaluate serum sodium and osmolality to screen for SIADH or diabetes insipidus. (American College of Endocrinology) 14

3. Dynamic Testing (When Baseline Results Are Equivocal)

• ACTH (cosyntropin) stimulation test (1 µg): Indicated when morning cortisol is between 3–15 µg/dL to confirm adrenal insufficiency. (Endocrine Society) 14
• GH stimulation testing: Considered for confirming GH deficiency, although patients already demonstrating ≥ 3 pituitary hormone deficits are highly likely to have GH deficiency and may forgo further testing. (American Association of Clinical Endocrinology) 14
• All dynamic tests must be performed before initiating glucocorticoid therapy to avoid false‑negative results. (Endocrine Society) 14

4. Imaging Recommendations

• Pituitary MRI with dedicated sellar cuts (with and without contrast) is recommended for any patient with confirmed hormonal deficiencies or a suspicion of structural pituitary disease. (American College of Radiology) 15
• MRI is superior to CT for detecting:
  
  • Pituitary adenomas (micro‑ or macroadenomas)
  • Empty sella syndrome
  • Hypophysitis or other inflammatory processes
  • Mass effect on the optic chiasm

5. Critical Clinical Pitfalls

• Do not start thyroid hormone replacement before confirming adequate cortisol replacement, as this can precipitate an adrenal crisis. (Endocrine Society) 14
• Free T4, not TSH, should guide levothyroxine dosing in central hypothyroidism, targeting the upper half of the reference range. (American Thyroid Association) 14
• Patients diagnosed with adrenal insufficiency must receive education on stress‑dosing, emergency injectable steroids, and obtain a medical‑alert bracelet. (Endocrine Society) 14

6. Referral to Endocrinology

• Early endocrinology consultation is advised for all patients with confirmed pituitary hormone deficiencies to assist with:
  
  • Interpretation of equivocal laboratory results
  • Initiation and titration of hormone replacement therapy
  • Patient education on emergency management of adrenal crisis
  • Pre‑operative hormonal optimization when surgery is planned

Imaging Recommendations for Isolated ACTH Deficiency with Empty Sella

Preferred Imaging Modality

• The American College of Radiology recommends using high‑resolution pituitary MRI (without mandatory IV contrast) as the first‑line study to characterize an empty sella and to confirm the diagnosis of isolated ACTH deficiency when structural abnormalities are suspected. This recommendation is based on expert consensus and imaging data presented in the ACR literature【16】【17】. (Evidence level: not specified).